111 related articles for article (PubMed ID: 1982015)
1. [Clinical investigation of urinary dipeptidyl aminopeptidase IV (DAP IV) activity in patients with primary glomerular diseases].
Nagata T
Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1161-8. PubMed ID: 1982015
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of dipeptidyl aminopeptidase i.v. in patients with renal diseases.
Wolf G; Scherberich JE; Nowack A; Stein O; Schoeppe W
Clin Nephrol; 1990 Mar; 33(3):136-42. PubMed ID: 2323111
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the excretion of urinary glycylprolyl dipeptidyl-aminopeptidase (GP-DAP) during normal pregnancy].
Negishi Y; Shibuya-Saruta H; Sugiyama M
Rinsho Byori; 1992 Feb; 40(2):199-204. PubMed ID: 1349929
[TBL] [Abstract][Full Text] [Related]
4. [Clinical implications of urine matrix metalloproteinases and their inhibitors in patients with chronic glomerulonephritis].
Li OA; Bobkova IN; Kozlovckaia LV
Ter Arkh; 2009; 81(8):10-4. PubMed ID: 19799193
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis].
Pulin AA; Brovko MIu; Kustova TIu; Kozlovskaia LV; Fomin VV; Mukhin NA
Ter Arkh; 2014; 86(6):24-9. PubMed ID: 25095652
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of nitric oxide levels in patients with chronic glomerulonephritis].
Barbarash OL; Pavlova VIu; Chesnokova IuL; Bazdyrev ED; Malyshev IIu; Manukhina EB
Klin Med (Mosk); 2007; 85(5):57-61. PubMed ID: 17665607
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum and urinary neopterins in patients with chronic renal disease.
Godai K; Uemasu J; Kawasaki H
Clin Nephrol; 1991 Sep; 36(3):141-6. PubMed ID: 1934670
[TBL] [Abstract][Full Text] [Related]
8. [Significance of the determination of urinary excretion of kidney injury molecule-1 (KIM-1) in the assessment of the activity and prognosis of chronic glomerulonephritis].
Brovko MY; Pulin AA; Kustova TY; Sholomova VI; Loshkareva OA; Taranova MV; Kozlovskaya LV
Ter Arkh; 2016; 88(6):51-57. PubMed ID: 27296262
[TBL] [Abstract][Full Text] [Related]
9. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of urinary glycyl-prolyl dipeptidyl aminopeptidase in patients with urological disease].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1990 Dec; 36(12):1391-6. PubMed ID: 1981655
[TBL] [Abstract][Full Text] [Related]
11. [Serum superoxide dismutase (SOD) activity in patients with renal disease by a spintrap method using electron spin resonance (ESR)].
Yokoyama K; Tomino Y; Yaguchi Y; Koide H; Ohmori D; Yamakura F
Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):809-14. PubMed ID: 8411759
[TBL] [Abstract][Full Text] [Related]
12. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
13. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
14. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and immunological properties of urinary angiotensinase A and dipeptidylaminopeptidase IV. Their use as markers in patients with renal cell injury.
Scherberich JE; Wiemer J; Schoeppe W
Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):663-8. PubMed ID: 1362894
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
[TBL] [Abstract][Full Text] [Related]
17. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis].
Rebenok AZh; Tikhonov II; Chizh AS
Ter Arkh; 1999; 71(8):62-7. PubMed ID: 10515041
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum dipeptidyl aminopeptidase IV in rats with adjuvant arthritis].
Kaku H; Yoshida K; Mizukawa H; Haruki E; Okazaki K; Inaba G
Ryumachi; 1991 Jun; 31(3):275-81. PubMed ID: 1683014
[TBL] [Abstract][Full Text] [Related]
19. [Glomerular function and urine acidification in chronic renal diseases].
Mizukami K
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):1-11. PubMed ID: 2161472
[TBL] [Abstract][Full Text] [Related]
20. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA
Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
